39086-05-0

Basic information

• Product Name: ethyl 3-bromo-4-oxocyclohexanecarboxylate
• Synonyms: ethyl 3-bromo-4-oxocyclohexanecarboxylate;ethyl 3-bromo-4-oxocyclohexane-1-carboxylate;tert-butyl 3-bromo-4-oxocyclohexanecarboxylate;Cyclohexanecarboxylic acid, 3-bromo-4-oxo-, ethyl ester
• CAS NO: 39086-05-0
• Molecular Formula: C₉H₁₃BrO₃
• Molecular Weight: 249.10172
• Mol File: 39086-05-0.mol
• Article Data: 13

Chemical Properties

• Appearance: /
• CAS DataBase Reference: ethyl 3-bromo-4-oxocyclohexanecarboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: ethyl 3-bromo-4-oxocyclohexanecarboxylate(39086-05-0)
• EPA Substance Registry System: ethyl 3-bromo-4-oxocyclohexanecarboxylate(39086-05-0)

Safety Data

• Hazardous Substances Data: 39086-05-0(Hazardous Substances Data)

Usage

Uses

Ethyl 3-Bromo-4-oxocyclohexane-1-carboxylate is a reagent in the process development of Pramipexole used in parkinson disease therapy.

Upstream product

• 3618-04-0 4-hydroxycyclohexyl carboxylic acid ethyl ester 
• 120-47-8 Ethyl 4-hydroxybenzoate 
• 17159-79-4 ethyl 4-oxocyclohexane-1-carboxylate 

Downstream Products

• 39086-04-9 3-(p-chlorophenoxy)-4-oxocyclohexanecarboxylic acid ethyl ester 
• 39090-65-8 3-(4-chloro-phenylthio)-4-oxo-cyclohexanecarboxylic acid ethyl ester 
• 1346701-77-6 2-(2-phenyl-4,5,6,7-tetrahydro-benzoxazole-6-carbonyl)cyclopropanecarboxylic acid 
• 1004527-81-4 ethyl 2-phenyl-4,5,6,7-tetrahydrobenzo[d]oxazole-6-carboxylate 
• 134136-00-8 ethyl 2-amino-4,5,6,7-tetrahydrobenzo[d]thiazole-6-carboxylate 
• 167545-91-7 ethyl 4,5,6,7-tetrahydro-1H-benzimidazol-5-carboxylate 
• 39086-10-7 3-(o-chlorophenoxy)-4-oxocyclohexanecarboxylic acid ethyl ester 
• 77528-71-3 2-Methyl-6-tosyloxymethyl-4,5,6,7-tetrahydrobenzo[d]thiazole 
• 77528-76-8 6-Tosyloxymethyl-4,5,6,7-tetrahydro-benzo[d]thiazole 

Relevant articles and documents

PROTEIN KINASE C AGONISTS

The present disclosure relates generally to certain diacylglycerol lactone compounds, pharmaceutical compositions comprising said compounds, and methods of making and using said compounds and pharmaceutical compositions. The compounds and compositions dis

ISOINDOLINE INHIBITORS OF ROR-GAMMA

Provided are novel compounds of Formula (I): pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are useful in the treatment of diseases and disorders mediated by RORγ. Also provided are pharmaceutical compositions comprising the novel compounds of Formula (I) and methods for their use in treating one or more inflammatory, metabolic, autoimmune and other diseases or disorders.

ANTI-INFECTIVE COMPOUNDS

The present invention relates to small molecule compounds having the general formula (I): wherein A is a moiety selected from the group consisting of formulae (A) to (K) and their use in the treatment of bacterial infections, in particular Tuberculosis.